Prostate Brachytherapy Utilization in the COVID-19 Era: A Cross-Sectional Study of Radiation Oncologists in the United States

PURPOSE/OBJECTIVE(S): Brachytherapy (BT) is indicated as monotherapy for lower risk prostate cancer (PC) or to boost external beam radiation therapy (EBRT) for higher risk disease. Despite its advantages, such as decreased treatment time and cost, BT utilization in the United States (US) is declinin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritter, A., Prasad, R.N., Jhawar, S.R., Gokun, Y., Vudatala, S., Wang, S.J., Martin, D.D., Pardo, D.A. Diaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
2539
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595461/
http://dx.doi.org/10.1016/j.ijrobp.2022.07.1211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595461/
http://dx.doi.org/10.1016/j.ijrobp.2022.07.1211

Ejemplares similares